期刊文献+

早期乳腺癌保乳治疗的局部复发因素分析 被引量:1

Analysis of local recurrence risk for early stage breast cancer after breast conservation therapy
暂未订购
导出
摘要 目的:探讨早期乳腺癌保乳治疗后局部复发的影响因素。方法:1988年6月~2005年6月我院304名临床1~2期早期乳腺癌患者进行了乳腺肿瘤局部切除,腋窝淋巴结清扫及术后放疗,所有肿瘤切缘均为阴性,多数患者接受了术后化疗,雌激素受体阳性者口服三苯氧胺。运用单一变量和多变量统计分析方法探讨年龄,腋窝淋巴结转移数量,肿瘤大小,雌激素孕激素受体,切缘距肿瘤距离及病理分型对局部复发的影响。结果:中位随访时间为97.2月,24名患者出现了局部复发,8年累计局部复发率为9.9%。雌激素受体阴性无论在单因素分析还是在多因素分析均与局部复发相关联,而腋窝淋巴结转移数量,肿瘤大小,切缘距肿瘤距离及病理分型与局部复发无关联。结论:年龄(小于40岁)、雌激素受体阴性是早期乳腺癌保乳治疗的局部复发的重要因素。 Objective:To analyze the recurrence factors for women with early stage breast cancer after breast conservation therapy (BCT). Methods:Between 1988 and 2005, 304 women with early stage underwent lumpectomy, axillary lymph node dissection and definitive irradiation. Most of patients received adjuvant chemotherapy. The patients with positive estrogen hormone receptors received tamoxifen administration. The risk factors of local recurrence were estimated by univariate and multivariate analyses. Results:The median follow up was 97.2 months. 24 cases of local recurrences occurred in the period of 8 ~ 204 month foUow-up. The 8-year local recurrence rates were 9.9%. Hormone receptor(negative) was a risk factor associated with local recurrence rate. However, tumor size, the number of positive axillary nodes, margin status and pathological type were not relative to local recurrence rate. Conclusion: Age and estrogen receptor are very important predictive factors of local recurrecne for women with early stage breast cancer after breast conservation therapy(BCT).
出处 《军医进修学院学报》 CAS 北大核心 2007年第1期17-19,共3页 Academic Journal of Pla Postgraduate Medical School
关键词 乳房切除术 区段 乳腺肿瘤 肿瘤复发 局部 mastectomy, segmental breast neoplasms neoplasm recurrence, local
  • 相关文献

参考文献10

  • 1Wazer DE Schmid,Ulnch PK,Ruthaer R,et al.The influence of age and extensive intraductal component histology up breast lumpectomy margin assessment as a predictor of residual tumor[J].Int J Radiat Biol Phys,1999,45(4):855-891.
  • 2Voogd A,Nielsen M,Peterse J,et al.Differences in risk factors For local and distant recurrence after breast conserving therapy or Mastectomy for stage Ⅱ breast cancer:pooled results of two large european randomized trials[J].J Clin Oncol,2001,19 (6):1688-1697.
  • 3Roberto J,Leester WU,Eleanor Harris,et al.Fifteen-year results of breast-conserving surgery and definitive irradiation for stage Ⅰ and Ⅱ breast carcinoma:The University of Pennsylvania experience[J].Int J Radiation Oncology Biol Phys,2004,58 (1):233 -240.
  • 4Bartelink H,Horiot JC,Poortmans P,et al.Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation[J].N Engl J Med,2001,345:1378-1387.
  • 5Kokobu M,Mtsumori M,Nxon A,et al.Outcome at a 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer:influence of margin status and systemic therapy on local recurrence[J].J Clin Oncol,2000,18(8):1668-1675.
  • 6Masaki Kokubo,Michihide Mitsumori,Satoshi Ishikura,et al.Results of breast-conserving therapy for Early Stage Breast Cancer[J].Am J Clin Oncol(CCT),2000,23(5):499-505.
  • 7Fisher B,Jeong JH,Anderson S,et al.Treatment of Axillary Lymph Node-Negative,Estrogen Receptor-Negative Breast Cancer:Updated Findings From National Surgical Adjuvant Breast and Bowel Project Clinical Trials[J].J Natl Cancer Inst,2004,96(24):1823-1831.
  • 8Early Breast Cancer Trialist'Collaborative Group.Tamoxifen for early breast cancer:an overview of the randomised trials[J].Lancet,1998,351-367.
  • 9Singletary SE.Margins in patients with early stage breast cancer treated with conservation therapy[J].Am J Surg,2002,184:383-383.
  • 10Jatoi I,Hilsenbeck SG.Significance of axillary lymph node metastasis in primary breast cancer[J].J Clin Oncol,1999,17:2334-2340.

同被引文献15

  • 1何英,唐利立.国人早期乳腺癌远处转移预报模型的研究[J].中国普通外科杂志,2007,16(4):360-362. 被引量:3
  • 2Bock GH,Putter H,Bonnema J, et al. The impact of locore- gional recurrences on metastatic progression in early-stage breast cancer:A muhistate model [J].Breast Cancer Res Treat,2009 117(2) :401-408.
  • 3Botteri E,Bagnardi V,Rotmensz N,et al. Analysis of local and regional recurrences in breast cancer after conservative surgery [J]. Ann Oncol,2010,21 (4) :723-728.
  • 4Bouganim N,Tsvetkova E,Clemons M,et al. Evolution of sites of recurrence after early breast cancer over the last 20 years : implications for patient care and future research [J]. Breast Cancer Res Treat, 2013,139 C 2 ) : 603-606.
  • 5Lower EE,Glass E,Blau R,et al. HER-2/neu expression in primary and metastatic breast cancer [J]. Breast Cancer Res Treat, 2009,113 (2) : 301-306.
  • 6Santinelli A,Pisa E,Stramazzotti D,et al. HER-2 status discrepancy between primary breast cancer and metastaticsites.Impact on target therapy [J]. International Journal of Cancer,2008,122(5) :999-1004.
  • 7Von MG,du Bois A,Sehrnidt M,et al. Trastuzumab beyond progression in human epidermal growth factor receptor 2, positive advanced breast eancer:A German Breast Group 26/ Breast International Group 03-05 study [J]. Journal of Clinical Ontology, 2009,27 (12) : 1999-2006.
  • 8贾宝洋,李海斌.乳腺癌复发转移的相关因素分析[J].现代预防医,2009.32(12):4377-4378.
  • 9袁中玉,王树森,朱美琴,郑磊,罗文标,周中梅,管忠震.不同分子亚型乳腺癌的临床特征和预后[J].中华肿瘤杂志,2008,30(6):456-461. 被引量:55
  • 10朱先明,钟志军.影响乳腺癌患者术后复发转移的因素分析[J].中国实用医药,2010,5(6):86-87. 被引量:20

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部